GlassScriptPhysician profile
Philip Ormond Merritt
NPI 1083696074
$449,674.38
in general payments reported to CMS, 2019-2025
19 companies · $6,939 in 2025
The $6,939 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161K · 2020: $139K · 2021: $105K · 2022: $26K · 2023: $12K · 2024: $265 · 2025: $6,939.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $6,874 · Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,245.00 |
| Travel and Lodging | $6,874.01 |
| Food and Beverage | $650.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $305,952.68 | 2019-2023 | Lrg Bone Propriety Osc Blades |
| Encore Medical, LP | $109,969.48 | 2019-2024 | Djo Surgical |
| Applied Medical Corporation | $26,035.00 | 2019-2023 | |
| Uoc USA INC | $6,939.01 | 2025 | Uts, Conformity, U-Mii, U2 Revision Stem, Psa, Ustar, U2 Knee, Conformity, U-Motion II, U-Star II, U2 |
| Stryker Corporation | $317.33 | 2021-2023 | Dall-Miles |
| Engage Uni, LLC | $114.00 | 2020 | |
| Amgen INC. | $76.40 | 2019-2021 | |
| Pacira Therapeutics, INC. | $51.18 | 2019-2020 | |
| Misonix INC | $40.15 | 2019 | |
| Boston Scientific Corporation | $29.96 | 2022 | |
| Applied Medical Resources Corporation | $28.01 | 2019-2023 | |
| Smith+Nephew, INC. | $21.14 | 2023 | Pico 7 |
| Bioventus LLC | $17.86 | 2021 | |
| Genentech USA, INC. | $17.55 | 2024 | Activase |
| Intellijoint Surgical INC. | $16.89 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $16.36 | 2019 | |
| Kci USA, INC. | $16.00 | 2023 | Prevena |
| Medartis INC. | $10.42 | 2019 | |
| Pajunk Medical Systems, LP | $4.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$203,440.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Merritt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.